Loading...
01/11 03:33
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call revealed a decline in total revenue and gross margins, with increased losses and reduced cash reserves. The Q&A highlighted concerns about commercial revenue decline and unresolved manufacturing issues. While A&D revenue growth is positive, overall guidance remains weak, and management's unclear responses add uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline.
Total Revenue Q4 2024 $47.4 million, a decrease of 9% compared to $51.9 million in Q4 2023 due to weakness in the industrial market and execution challenges.
Product Revenue Q4 2024 $31.7 million, down from $37.9 million in Q4 2023, impacted by the same factors as total revenue.
Development Revenue Q4 2024 $15.7 million, a 12% year-over-year increase.
Total Revenue FY 2024 $198.5 million, a decrease of 5% compared to $209.9 million in 2023, primarily due to declines in microfabrication and industrial markets.
Aerospace and Defense Revenue FY 2024 $109.5 million, an increase of 20% year-over-year.
Aerospace and Defense Products Revenue FY 2024 $47.7 million, a 25% year-over-year increase.
Aerospace and Defense Development Revenue FY 2024 $61.9 million, a 16% year-over-year increase.
Total Gross Margin Q4 2024 2%, down from 19% in Q4 2023, negatively impacted by $6 million in non-routine charges.
Product Gross Margin Q4 2024 1%, down from 22% in Q4 2023; adjusted for non-routine charges, it would be approximately 20%.
Development Gross Margin Q4 2024 6%, down from 9% in Q4 2023.
Total Gross Margin FY 2024 17%, compared to 22% in 2023, due to lower sales and production volumes.
Product Gross Margin FY 2024 21%, down from 27% in 2023, impacted by lower sales and inventory charges.
Non-GAAP Operating Expenses Q4 2024 $17.7 million, slightly up from $17.4 million in Q4 2023.
GAAP Operating Expenses Q4 2024 $27.6 million, including $4.3 million in restructuring charges.
Adjusted EBITDA Q4 2024 Loss of $11.3 million, compared to a gain of $3.3 million in Q4 2023.
GAAP Net Loss Q4 2024 $25 million or $0.51 per share, compared to a net loss of $13.2 million or $0.28 per share in Q4 2023.
Total Cash and Investments End of FY 2024 $100.9 million, down from $113.1 million at the end of 2023.
Inventory End of FY 2024 $40.8 million, down from $52.1 million at the end of 2023.
New Product Development: nLIGHT is making significant progress on its Healthy 2 program, a multi-year DoD-funded $171 million initiative to develop a one-megawatt high-energy laser, with shipments expected to accelerate throughout 2025.
Additive Manufacturing Technology: nLIGHT introduced the Corona AFX dynamic beam-shaping technology, enhancing printing speed and flexibility for metal additive manufacturing, which is gaining traction in aerospace and defense.
Market Expansion in Aerospace and Defense: Revenue from aerospace and defense grew to over 60% of total sales, reaching $110 million, with a 20% year-over-year increase.
International Market Interest: Israel's Ministry of Defense announced a $500 million investment in the Iron Beam laser system, indicating a growing international interest in directed energy systems.
Operational Efficiency: nLIGHT completed the transition of manufacturing out of China, positioning itself to support growth in defense business.
Backlog Growth: The backlog increased by over 50% year-over-year to a record $167 million, indicating strong future demand.
Strategic Shift to Defense: nLIGHT's focus has shifted significantly towards aerospace and defense, which is now the primary growth driver for the company.
Vertical Integration Strategy: nLIGHT leverages its entire technology stack for directed energy, enhancing performance and cost-effectiveness.
Competitive Pressures: nLIGHT's commercial markets faced a 25% year-over-year revenue decline due to increasing competition from China and muted global manufacturing demand.
Regulatory Issues: The company is aligned with the Department of Defense's priorities, but execution challenges remain due to the highly technical nature of defense work and the timing of government programs.
Supply Chain Challenges: The transition out of China for manufacturing operations was completed, but the company still faces execution challenges in microfabrication and product delivery.
Economic Factors: Overall customer demand has decreased, impacting sales and production volumes, which has led to lower gross margins and increased operating expenses.
Inventory Management: The company reported non-routine charges of approximately $6 million related to inventory reserves on products for the industrial market, indicating potential inventory management issues.
Operational Challenges: The company experienced execution challenges in delivering defense products, which contributed to a shortfall in revenue relative to guidance.
Aerospace and Defense Revenue Growth: Revenue from aerospace and defense grew to more than 60% of total sales, with a 20% year-over-year increase to a record $110 million.
Backlog Growth: Backlog increased by more than 50% year-over-year to a record $167 million.
Healthy 2 Program: A multi-year DoD-funded $171 million program to develop a one-megawatt high-energy laser, with completion expected in 2026.
Iron Dome Initiative: The U.S. government is focusing on developing non-kinetic missile defense capabilities, which nLIGHT is positioned to benefit from.
Metal Additive Manufacturing: nLIGHT sees long-term growth opportunities in metal additive manufacturing, particularly in aerospace and defense.
2025 Revenue Growth Expectation: nLIGHT expects revenue growth of at least 25% in aerospace and defense markets in 2025.
First Quarter 2025 Revenue Guidance: Expected revenue range of $45 million to $51 million, with a midpoint of $48 million.
First Quarter 2025 Gross Margin Guidance: Product gross margin expected to be in the range of 16% to 20%, and total gross margin range of 13% to 17%.
Adjusted EBITDA Guidance: Expected adjusted EBITDA for Q1 2025 to be in the range of negative $6 million to negative $3 million.
Breakeven Adjusted EBITDA: Expected quarterly revenue range for breakeven adjusted EBITDA is $55 million to $60 million.
Share Repurchase Program: None
The earnings call summary shows strong financial metrics, improved non-GAAP net income, and positive cash flow. Despite some concerns about gross margin decline, the growth in advanced development and the HELSI-2 program provide optimism. The Q&A session reveals confidence in offsetting future revenue losses and highlights opportunities in counter-drone technology. The company's strategic initiatives and guidance suggest a positive market reaction, likely resulting in a stock price increase of 2% to 8%.
The earnings call reveals strong financial performance with significant growth in defense revenue and improved gross margins. While commercial revenue declined YoY, it showed sequential improvement. The Q&A session highlighted management's confidence in future growth, particularly in defense and international markets, despite some uncertainty about specific future projections. The improvement in non-GAAP net income and positive adjusted EBITDA also bolster a positive outlook. Given these factors, the stock is likely to experience a positive movement, although the lack of specific guidance for 2026 and some execution risks temper the outlook slightly.
The earnings call highlights strong financial performance with record revenue growth in aerospace and defense, improved margins, and a reduced net loss. The Q&A section reveals management's optimism about future growth despite tariff uncertainties, with plans to mitigate risks through alternative sourcing. The positive sentiment is further reinforced by the expectation of a stronger second half and continued backlog growth. These factors suggest a likely positive stock price movement over the next two weeks.
The earnings call revealed a decline in total revenue and gross margins, with increased losses and reduced cash reserves. The Q&A highlighted concerns about commercial revenue decline and unresolved manufacturing issues. While A&D revenue growth is positive, overall guidance remains weak, and management's unclear responses add uncertainty. These factors suggest a negative sentiment, likely leading to a stock price decline.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
